A novel class of dual mPGES-1/5-LO inhibitors based on the α-naphthyl pirinixic acid scaffold.
Bioorg Med Chem Lett
; 21(5): 1329-33, 2011 Mar 01.
Article
em En
| MEDLINE
| ID: mdl-21310608
ABSTRACT
Dual inhibition of microsomal prostaglandin E(2) synthase-1 (mPGES-1) and 5-lipoxygenase (5-LO) represents a promising strategy in the development of novel anti-inflammatory drugs targeting the arachidonic acid cascade. Herein, a class of α-naphthyl pirinixic acids is characterized as dual mPGES-1/5-LO inhibitors. Systematic structural variation was focused on the lipophilic backbone of the scaffold and yielded detailed structure-activity relationships (SAR) with compound 16 (IC(50) mPGES-1=0.94 µM; IC(50) 5-LO=0.1 µM) showing the most favorable in vitro pharmacological profile.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pirimidinas
/
Araquidonato 5-Lipoxigenase
/
Inibidores de Lipoxigenase
/
Oxirredutases Intramoleculares
/
Anti-Inflamatórios
/
Naftóis
Idioma:
En
Ano de publicação:
2011
Tipo de documento:
Article